NCT00733187View on ClinicalTrials.gov

Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Advanced Solid Tumors
Interventions
DRUG

ABT-869

0.25 mg/kg

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT00733187 - Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869 | Biotech Hunter | Biotech Hunter